BSEGeneral3h ago · 3 Oct 2026, 05:32 pm

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Transgene Biotek Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L85195TG1990PLC011065</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December, as applicable ....

Transgene Biotek Ltd · 526139

✦ AI SummaryRegulatory

Transgene Biotek Ltd has confirmed that it does not fall under the category of 'Large Corporate' as per SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, and BSE Circular No. LIST/COM/05/2019-20 dated April 11, 2019.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Transgene Biotek Ltd - 526139 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Attachments (1)

📄

1d21225a-3faa-48b5-a843-91656d82d724.pdf

pdf

Download →
View document text
Date: 03-10-2026 The General Manager Listing Compliance Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001 Ref: - Scrip Code/ SYMBOL: 526139 Dear Sir / Madam, Subject: Confirmation regarding not falling under Large Corporate criteria pursuant to SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018 and BSE Circular No. LIST/COM/05/2019-20 dated April 11, 2019 Pursuant to SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, relating to fund raising by issuance of debt securities by Large Corporates, and BSE Circular No. LIST/COM/05/2019-20 dated April 11, 2019, we hereby confirm that Transgene Biotek Limited does not fulfil the criteria specified in Para 2.2 of the aforesaid SEBI Circular and, accordingly, the Company does not fall under the category of “Large Corporate” as defined under the said Circular. The Company therefore confirms that the provisions applicable to Large Corporates under the aforesaid SEBI Circular are not applicable to the Company. We kindly request you to take the same on record. Thanking you Yours Sincerely For TRANSGENE BIOTEK LIMITED DR K KOTESWARA RAO CHAIRMAN & MANAGING DIRECTOR DIN: 02287235 Plot 69 & 70, IDA Bollaram, Sangareddy District – 502 325, Telangana, India Ph: +91-40-65589499 Fax: +91-8458-279755 Web: www.transgenebiotek.com Email: info@transgenebiotek.com, CIN No: L85195AP1990PLC011065